Author:
Nubiola A.,Ternianov A.,Remolins I.
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference10 articles.
1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med.,2015
2. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus;Heerspink;Circulation.,2016
3. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, doubleblind, phase 3, randomised controlled trial;Dandona;Lancet Diabetes Endocrinol.,2017
4. Effects of sotagliflozin added to insulin in patients with type 1 diabetes;Garg;N Engl J Med.,2017
5. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: Possible mechanism and contributing factors;Ogawa;J Diabetes Investig.,2016
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献